SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI of $0 in Q1 FY2026

Q1 FY2026 Accumulated OCI was $0.

Context

  • Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Accumulated OCI vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Accumulated OCI amounts to 0.0% of total assets for SGP, versus a peer median of 0.3%.
SGP Competitors
Accumulated OCI for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$21.71B USD-1.5%+3.8%69.2%
OCSOculis Holding AGMar 2026CHF 30.1M CHF+1639.0%+134.1%12.4%
GKOSGlaukos CorporationJun 2026$2.38M USD-17.0%—0.3%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$802K USD-13.1%+6.9%0.3%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$0 USD——0.0%
OCULOcular Therapeutix, Inc.Mar 2026$0 USD——0.0%
SGHTSight Sciences, Inc.Mar 2026$0 USD——0.0%
RXSTRxSight, Inc.Mar 2026-$67K USD-546.7%—0.0%
STAASTAAR Surgical CompanyApr 2026-$6.78M USD-20.9%—1.5%
BLCOBausch + Lomb CorporationJun 2026-$1.22B USD-2.3%—8.8%
Peer median (excluding SGP) —-13.1%+6.9%0.3%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.